08.00-08.30 Arrival - Badge Collection
Welcome Message from the Meeting Directors
What is the E.V.A. Meeting About?
08.45-09.30 What is New and Interesting in Dialysis Access?
Moderators: K. Katsanos (Greece), D. Karnabatidis (Greece)
08.45-08.52 The Nephrologist’s view P.R Chaudhury (USA)
08.53-09.00 The Vascular Surgeon’s view D. Shemesh (Israel)
09.01-09.08 The Interventional Radiologist’s view P. Kitrou (Greece)
09.09-09.16 Multi-Disciplinary Meeting for Dialysis Access. Is it Really Needed? Z. Haskal (USA)
09.17-09.30 Discussion
Panel: J. Tordois (Netherlands), M.A. Twalah (KSA), G. Sengoelge (Austria)
09.30-10.30 Trial Updates
Moderators: D. Karnabatidis (Greece), J.M. Abadal (Spain)
09.30-09.37 Lutonix United States & Canada PAS SO. Trerotola (USA)
09.38-09.45 The PAVE Study N. Karunanithy (UK)
09.46-09.53 The Lutonix Global AV Registry D. Karnabatidis (Greece)
09.54-10.01 Drug-Coated Balloons for the treatment of Symptomatic Central Venous Stenosis P. Kitrou (Greece)
10.02-10.08 The AVeVA & AVeNEW studies B. Dolmatch (USA)
10.09-10.16 Clinical Trial End Points for Vascular Access P.R Chaudhury (USA)
10.16-10.30 Discussion
10.30-11.30 Declotting Procedures
Moderators: D. Karnabatidis (Greece), B. Dolmatch (USA)
10.30-11.00 LIVE Case from Patras University Hospital K. Katsanos (Greece)
10.59-11.06 What do the Guidelines Suggest? What are the Options? A. Khwaja (UAE)
11.07-11.14 From Fundamentals to Tips & Tricks M.A. Twalah (KSA)
11.15-11.22 Thrombectomy Devices Have Nothing to Offer N. Karunanithy (UK)
11.23-11.30 Thrombectomy Devices Make the Difference O. Jaffer (UK)
11.30-12.00 Coffee Break
12.00-12.45 Dialysis Access Treatment Pathway
Moderators: D. Karnabatidis (Greece), G. Lampropoulos (Greece)
12.00-12.07 Dialysis Prevalence Across the Globe L. Balta (Greece)
12.08-12.15 What is a nephrologist expecting from Endovascular Treatment? M. Papasotiriou (Greece)
12.16-12.23 How to get started. What Cases to Pick D. Savio (Italy)
12.24-12.31 Cost Effectiveness K. Katsanos (Greece)
12.31-12.45 Discussion
Panel: B. Dolmatch (USA), M.Lazarides (Greece), J. Ibeas (Spain)
12.45-13.30 BD Symposium: AVF Creation with The WavelinQ Procedure
Moderators: D. Karnabatidis (Greece), P. Kitrou (Greece)
Patient Selection Criteria T. Steinke (Germany)
Data Update O. Jaffer (UK )
Mapping and Case Presentation P. Kitrou (Greece)
13.30-14.30 Lunch Break
14.30-15.15 Central Venous Catheters: Difference Lies in the Details
Moderators: O. Jaffer (UK), G. Saracino (Italy)
Different Configurations, Different Results? P. Papadimatos (Greece)
Stenotic central veins. How to approach and treat J. Gilbert (UK)
Infected CVC. When to remove, how to treat, what to do next G. Sengoelge (Austria)
Last Option Catheter Access – New Techniques for Tunneling E. Kehagias (Greece)
15.15-16.00 Guidelines Update
Moderators: D. Karnabatidis (Greece), J. Tordois (Holland)
K-DOQI SO. Trerotola (USA)
ESVS for Vascular Access J. Tordoir (Netherlands)
SIR Guidelines Z. Haskal (USA)
Spanish Guidelines for HD Access J. Ibeas (Spain)
UK Consensus on Dialysis O. Jaffer (UK)
08.00-09.00 Development in the background
Moderators: S. Spiliopoulos (Greece), M. Lazarides (Greece)
08.00-08.10 Histology and Histopathology of vascular access stenosis G. Sengoelge (Austria)
08.11-08.21 Bio-Engineering J. Lawson (USA)
08.22-08.32 Systemic therapy M. Papasotiriou (Greece)
08.33-08.45 How close are we to a tailored therapy for the HD patient? P.R Chaudhury (USA)
08.45-09.00 Discussion
09.00-10.00 Drug-Coated Devices. Do we finally have a new tool?
Moderator: Karnabatidis (Greece)
09.00-09.30 LIVE Case from Patras University HospitalP. Kitrou (Greece)
09.31-09.38 Overview of evidence so Far S. Spiliopoulos (Greece)
09.39-09.46 What does the future hold? K. Katsanos (Greece)
09.47-10.00 Discussion
Panel: SO. Trerotola (USA), T. Steinke (Germany)
10.00-11.45 Immature Fistulas – Early Cannulation Grafts
Moderators: S. Kakkos (Greece), J. Gilbert (UK)
10.00-10.07 Immature AVF. A clinical entity. What leads to G. Saracino (Italy)
10.08-10.15 Maturing an Immature Fistula. How to do it? What is the evidence? SO. Trerotola (USA)
10.16-10.23 Early Cannulation Grafts – What do they offer to HD? P.J. Ko (Taiwan)
10.24-10.31 Is there an algorithm to success? J. Lawson (USA)
10.32-10.45 Discussion
10.45-11.30 Symptomatic Central Venous Stenosis/Occlusion: The last frontier
Moderators: D. Savio (Italy) T. Steinke (Germany)
10.45-10.52 HERO Graft – Recorded Case J. Gilbert (UK)
10.53-11.00 What does Surgical Treatment has to offer? D. Shemesh (Israel)
11.01-11.08 Surfacer – Recorded Case G. Sengoelge (Austria)

11.09-11.16 What do the Guidelines suggest? M. Krokidis (Greece)
11.17-11.23 Endovascular Salvage Procedures for Central Veins. When Enough is Enough? A. Khwaja (UAE)
11.23-11.30 Discussion
11.30-12.00 Coffee break
12.00-12.45 Treating the juxta-anastomotic stenosis.
Moderators: G. Georgiadis (Greece), K. Katsanos (Greece)
Drug-Coated Balloons M. Theofanis (Greece)
Covered Stents B. Dolmatch (USA)
Plain Old Balloon – Cutting Balloon Angioplasty J.M. Abadal (Spain)
12.45-13.30 BD Symposium: Vascular Access Management Evidence-Based Solutions
Moderators: D. Karnabatidis (Greece), Z. Haskal (USA)
The Lutonix® clinical program for the treatment of dysfunctional vascular access SO. Trerotola (USA)
Covera™ Covered Stent for the Treatment of Fistulas and Grafts B. Dolmatch (USA)
Treatment Algorithm P. Kitrou (Greece)
Presentation of Cases K. Katsanos (Greece)
13.30-14.30 Lunch Break
14.30-16.00 Percutaneous AVF Creation
Moderators: P. Kitrou (Greece), TBA
WavelinQ – Recorded Case P. Kitrou (Greece)
Ellipsys – Recorded Case R. Loffroy (France)
Candidates: How to pick one T. Steinke (Germany)
What is the experience so far? T. Steinke (Germany)